
Home » VIDA Diagnostics’ Deep Learning Algorithm Gets FDA Clearance
VIDA Diagnostics’ Deep Learning Algorithm Gets FDA Clearance

September 22, 2020
The FDA has granted 510(k) clearance for VIDA Diagnostics’ VIDA algorithm, artificial intelligence-based (AI) software that analyzes lung scans.
The algorithm is an addition to the company’s LungPrint suite that helps to improve lung- imaging assessments by including disease probability and progression.
The AI-powered analysis “empowers physicians to develop personalized treatment plans that can improve outcomes and quality of life,” the company said.
Related Events
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr